Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
Clinical trial NCT02808416 · COMPLETED
Trial details
- NCT number
- NCT02808416
- Sponsor
- Guangdong 999 Brain Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-10-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.